Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden
- PMID: 11596039
- DOI: 10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r
Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden
Abstract
Background: Carcinoids are rare indolent neuroendocrine tumors, mainly located in bowel, stomach, and lung. Their etiology is virtually unknown although a family history is a minor cause.
Methods: Site specific incidence trends and several risk factors of carcinoid tumors were studied based on the nationwide Swedish Family-Cancer Database of 10.2 million individuals and their more than 1 million tumors. Data on a total of 5184 carcinoid tumors were retrieved from the Cancer Registry covering years 1958-1998.
Results: The overall age-adjusted incidence rates were 2.0 for men and 2.4/100,000 for women in 1983-1998. Appendix was the main site for women whereas small intestine was the main site for men. The incidence of all carcinoids, including those at the main sites increased during the follow-up period but appeared to plateau in the middle of the 1980s. Appendiceal carcinoids showed an unusually early onset with a maximum incidence at age 15-19 years for women and 20-29 years for men. Among women, parity was not related to the age specific incidence of carcinoid tumors. A Poisson regression analysis showed that family history of carcinoids in first-degree relatives (relative risk, 3.6), well educated social background (relative risk for professionals, 2.8), and birth in large cities were risk factors.
Conclusions: The data suggest that the increase in carcinoid tumors may be largely ascribed to the application of advanced medical viewing techniques that detect asymptomatic tumors. However, the difference in incidence between men and women in appendiceal tumor may be real and independent of parity.
Copyright 2001 American Cancer Society.
Similar articles
-
Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden.Int J Cancer. 2001 Nov 1;94(3):444-8. doi: 10.1002/ijc.1473. Int J Cancer. 2001. PMID: 11745428
-
A 5-decade analysis of 13,715 carcinoid tumors.Cancer. 2003 Feb 15;97(4):934-59. doi: 10.1002/cncr.11105. Cancer. 2003. PMID: 12569593
-
A retrospective analysis of 1570 appendiceal carcinoids.Am J Gastroenterol. 1998 Mar;93(3):422-8. doi: 10.1111/j.1572-0241.1998.00422.x. Am J Gastroenterol. 1998. PMID: 9517651
-
Natural history of intestinal carcinoids.Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S108-10. Ital J Gastroenterol Hepatol. 1999. PMID: 10604113 Review.
-
Neuroendocrine tumours (carcinoids) of the appendix.Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):729-38. doi: 10.1016/j.bpg.2005.06.003. Best Pract Res Clin Gastroenterol. 2005. PMID: 16253897 Review.
Cited by
-
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.Br J Cancer. 2013 Feb 5;108(2):301-10. doi: 10.1038/bjc.2012.560. Epub 2013 Jan 15. Br J Cancer. 2013. PMID: 23322194 Free PMC article.
-
Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors.Front Endocrinol (Lausanne). 2021 Feb 26;12:622693. doi: 10.3389/fendo.2021.622693. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33732215 Free PMC article. Review.
-
Neuroendocrine tumor of the ampulla of Vater with distant cystic lymph node metastasis: a case report.Surg Case Rep. 2016 Dec;2(1):73. doi: 10.1186/s40792-016-0202-1. Epub 2016 Jul 25. Surg Case Rep. 2016. PMID: 27457078 Free PMC article.
-
Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism.Int J Endocrinol. 2019 Aug 1;2019:4518742. doi: 10.1155/2019/4518742. eCollection 2019. Int J Endocrinol. 2019. PMID: 31467527 Free PMC article.
-
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.J Endocrinol Invest. 2024 Apr;47(4):959-971. doi: 10.1007/s40618-023-02213-1. Epub 2023 Oct 14. J Endocrinol Invest. 2024. PMID: 37837555 Free PMC article.